Download Final Program - Society for Immunotherapy of Cancer
Download Final Program - Society for Immunotherapy of Cancer
Download Final Program - Society for Immunotherapy of Cancer
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
General Meeting In<strong>for</strong>mationOral AbstractsThe iSBTc has selected the highest scoring abstract entries <strong>for</strong>oral presentations within the various meeting sessions. Each oralabstract presentation is followed by a five-minute question andanswer period. For a complete listing <strong>of</strong> the selected oral abstractpresenters, please see page 25.Poster AbstractsAbstracts selected <strong>for</strong> poster presentation <strong>for</strong> the 23rd AnnualMeeting are on display at various times on the 4th Floor in theGarden Pavilion.Posters in the categories <strong>of</strong>: Adoptive Transfer; Dendritic Cells;Endpoints, Response Criteria <strong>for</strong> Clinical Trial Design; Enhancing<strong>Cancer</strong> Vaccines; and TH-17, Cytokines and T Cell Subsets (#1-72)will be presented from 12:00 PM – 1:00 PM and 5:30 PM – 6:30PM on Friday and available <strong>for</strong> viewing from 10:00 AM – 7:30 PMon Friday.Posters in the categories <strong>of</strong>: <strong>Cancer</strong> and Inflammation; <strong>Cancer</strong> StemCells and the Host Response; Co-stimulation / Immunoregulation;Infectious Agent Vectors; Innate Immunity to Tumors; New Agents;Trafficking and in vivo Imaging; Tumor Escape / Tumor Microenvironment;Tumor Targeting Monoclonal Antibodies; and Late-BreakingAbstracts (#73-141) will be presented from 12:00 PM – 1:00 PMand 5:30 PM – 6:30 PM on Saturday and available <strong>for</strong> viewing from10:00 AM – 7:15 PM on Saturday. Please see page 54 or the PosterAbstract Book <strong>for</strong> this year’s poster listings. During the presentationtimes listed, designated posters are staffed by their respective authors,allowing <strong>for</strong> in<strong>for</strong>mation exchange and interaction betweenresearchers and attendees.Poster Hall HoursFriday Posters 10:00 AM – 7:30 PMAdoptive TransferDendritic CellsEndpoints, Response Criteria <strong>for</strong> Clinical Trial DesignEnhancing <strong>Cancer</strong> VaccinesTH-17, Cytokines and T Cell SubsetsLate-Breaking AbstractsTo fulfill iSBTc’s commitment to the most cutting-edge science, latebreakingabstract submission was <strong>of</strong>fered from August – September.The abstracts submitted were not available in time <strong>for</strong> printing in theJournal <strong>of</strong> <strong>Immunotherapy</strong> or consideration <strong>for</strong> oral presentation,but are available <strong>for</strong> viewing as posters on Saturday, November 1 inthe “Late-Breaking Abstract” category. Copies <strong>of</strong> the late-breakingabstracts are also available in the Poster Abstract Book distributedwith the meeting materials.Poster Presentations/Staffing HoursFriday Presentations: 12:00 PM - 1:00 PM & 5:30 PM - 6:30 PMPoster Numbers 1-72 (authors must be present)Adoptive Transfer (1-13)Dendritic Cells (14-21)Endpoints, Response Criteria <strong>for</strong> Clinical Trial Design (22-24)Enhancing <strong>Cancer</strong> Vaccines (25-59)TH-17, Cytokines and T Cell Subsets (60-72)Saturday Presentations: 12:00 PM - 1:00 PM & 5:30 PM - 6:30 PMPoster Numbers 73-141 (authors must be present)<strong>Cancer</strong> and Inflammation (73-77)<strong>Cancer</strong> Stem Cells and the Host Response (78)Co-stimulation / Immunoregulation (79-84)Infectious Agent Vectors (85-87)Innate Immunity to Tumors (88-94)New Agents (95-104)Trafficking and in vivo Imaging (105)Tumor Escape / Tumor Microenvironment (106-125)Tumor Targeting Monoclonal Antibodies (126-129)Late-Breaking Abstracts (130-141)Saturday Posters 10:00 AM – 7:15 PM<strong>Cancer</strong> and Inflammation<strong>Cancer</strong> Stem Cells and the Host ResponseCo-stimulation / ImmunoregulationInfectious Agent VectorsInnate Immunity to TumorsNew AgentsTrafficking and in vivo ImagingTumor Escape / Tumor MicroenvironmentTumor Targeting Monoclonal AntibodiesLate-Breaking Abstracts
Change language